At present, nucleic acid detection has become a normal project under epidemic prevention and control. Behind this, it is inseparable from the continuous development and improvement of detection technology and equipment. At the beginning of the new year, Changsha Imadek Intelligent Technology Co., Ltd. (hereinafter referred to as "Imadek"), which has the largest market share in the sample processing system in China, received a large order of 50 million yuan and ushered in a "good start" in 2022.

Imadek staff are debugging equipment

On January 12, the reporter saw the slogan "Fighting for 12 days, overcoming difficulties, and advancing strongly" at Imadek's factory in Xingsha Industrial Base, and the slogan on the wall was particularly eye-catching. The staff were debugging the machinery and equipment non-stop. The equipment is the latest order for the sample processing system signed by Imadek this year. After accurate debugging, it will be sent to Zhejiang, Fujian, Tianjin and other places and foreign markets.

From 20.2 million yuan in revenue in 2020 to more than 80 million yuan last year, our revenue has quadrupled. " said Mr. Du Lin , the Medick Deputy General Manager of Imadek. From consolidating the foundation to switching the "track", 2021 will become the "first year" for Imadek to fully sprint into the field of IVD automation, and its technology and volume have reached a new level.

The sample processing system independently developed by Imadek

As a start-up company, in 2016, Imadek was incubated by Sany Zhongchuang in Changsha Economic Development Zone, focusing on the blood system, and developed the first intelligent blood storage and supply management system in China. At the end of 2020, Imadek began to enter the field of IVD and related fields of molecular diagnosis, and the well-known "COVID nucleic acid detection" belongs to the molecular diagnosis.

According to Mr. Du, the nucleic acid testing generally includes four parts: sample pretreatment, nucleic acid extraction, PCR (polymerase chain reaction) reaction system preparation, and PCR amplification. Imadek focuses on the first and third parts.  Independently developed by Imadek, with the core power system, the sample processing system can realize the non-equidistant sample dispensing and micro-precision pipetting. And the whole process from sample dispensing, sample preparation to PCR reaction system construction can be constructed automatically, though which would require manual labor in the past. Last but most importantly the whole process ( 1dimension or 2 dimension code scanning, uncapping, pipetting, capping and PCR set-up) is in a close environment. At the same time, the equipment also has a built-in negative pressure filtration system and ultraviolet disinfection system, and the filtration efficiency of 0.3um diameter particles is not less than 99.999%, which can effectively prevent the leakage of pollutants and reduce the infection risk of testing personnel.

Imadek's factory in Xingsha Industrial Base Xingchang

"Our sample processing system Magic-8000 can complete the whole process: scanning, uncapping, pipetting and capping 96 samples in 20 minutes. It can process up to 6,000 samples per day, which greatly improves the detection efficiency." Mr. Du Lin introduced. At present, the Magic series of automatic sample processing system developed by Imadek has become a hot-selling product, and the equipment has been applied to the CDC, mobile test stations, mobile field hospitals, and sample testing institutes all over the country, and has won wide acclaim.

"It is expected that in 2022, our revenue will reach 200 million yuan." said Mr. Du Lin.

At present, in order to expand production capacity, Imadek has purchased more than 6,000 square meters of workshops in Kaiyang Intelligent Manufacturing Industrial Park, Xingsha Industrial Base, to build Imadek's headquarters, and set up engineering departments and R&D departments in Changsha and Shenzhen to focus on cutting-edge technology research and development and core production.

Changsha Imadek Intelligent Technology Co., Ltd.

In the future, Imadek will continue to focus on the field of life science automation, extend the supporting industry chain, rely on its own core technological advantages, and realize the sustainable development of nucleic acid detection pretreatment, enzyme immunity, mass spectrometry and other technologies in the post-epidemic era, and establish a scientific research laboratory. and R&D center, complete the upgrade and expansion from IVD automation to automation in the field of life sciences, become the first leading enterprise in the industry focusing on automation in the field of life sciences, and create new kinetic energy and new advantages to lead the development of the industry.

At present, nucleic acid detection has become a normal project under epidemic prevention and control. Behind this, it is inseparable from the continuous development and improvement of detection technology and equipment. At the beginning of the new year, Changsha Imadek Intelligent Technology Co., Ltd. (hereinafter referred to as "Imadek"), which has the largest market share in the sample processing system in China, received a large order of 50 million yuan and ushered in a "good start" in 2022.

Imadek staff are debugging equipment

On January 12, the reporter saw the slogan "Fighting for 12 days, overcoming difficulties, and advancing strongly" at Imadek's factory in Xingsha Industrial Base, and the slogan on the wall was particularly eye-catching. The staff were debugging the machinery and equipment non-stop. The equipment is the latest order for the sample processing system signed by Imadek this year. After accurate debugging, it will be sent to Zhejiang, Fujian, Tianjin and other places and foreign markets.

From 20.2 million yuan in revenue in 2020 to more than 80 million yuan last year, our revenue has quadrupled. " said Mr. Du Lin , the Medick Deputy General Manager of Imadek. From consolidating the foundation to switching the "track", 2021 will become the "first year" for Imadek to fully sprint into the field of IVD automation, and its technology and volume have reached a new level.

The sample processing system independently developed by Imadek

As a start-up company, in 2016, Imadek was incubated by Sany Zhongchuang in Changsha Economic Development Zone, focusing on the blood system, and developed the first intelligent blood storage and supply management system in China. At the end of 2020, Imadek began to enter the field of IVD and related fields of molecular diagnosis, and the well-known "COVID nucleic acid detection" belongs to the molecular diagnosis.

According to Mr. Du, the nucleic acid testing generally includes four parts: sample pretreatment, nucleic acid extraction, PCR (polymerase chain reaction) reaction system preparation, and PCR amplification. Imadek focuses on the first and third parts.  Independently developed by Imadek, with the core power system, the sample processing system can realize the non-equidistant sample dispensing and micro-precision pipetting. And the whole process from sample dispensing, sample preparation to PCR reaction system construction can be constructed automatically, though which would require manual labor in the past. Last but most importantly the whole process ( 1dimension or 2 dimension code scanning, uncapping, pipetting, capping and PCR set-up) is in a close environment. At the same time, the equipment also has a built-in negative pressure filtration system and ultraviolet disinfection system, and the filtration efficiency of 0.3um diameter particles is not less than 99.999%, which can effectively prevent the leakage of pollutants and reduce the infection risk of testing personnel.

Imadek's factory in Xingsha Industrial Base Xingchang

"Our sample processing system Magic-8000 can complete the whole process: scanning, uncapping, pipetting and capping 96 samples in 20 minutes. It can process up to 6,000 samples per day, which greatly improves the detection efficiency." Mr. Du Lin introduced. At present, the Magic series of automatic sample processing system developed by Imadek has become a hot-selling product, and the equipment has been applied to the CDC, mobile test stations, mobile field hospitals, and sample testing institutes all over the country, and has won wide acclaim.

"It is expected that in 2022, our revenue will reach 200 million yuan." said Mr. Du Lin.

At present, in order to expand production capacity, Imadek has purchased more than 6,000 square meters of workshops in Kaiyang Intelligent Manufacturing Industrial Park, Xingsha Industrial Base, to build Imadek's headquarters, and set up engineering departments and R&D departments in Changsha and Shenzhen to focus on cutting-edge technology research and development and core production.

Changsha Imadek Intelligent Technology Co., Ltd.

In the future, Imadek will continue to focus on the field of life science automation, extend the supporting industry chain, rely on its own core technological advantages, and realize the sustainable development of nucleic acid detection pretreatment, enzyme immunity, mass spectrometry and other technologies in the post-epidemic era, and establish a scientific research laboratory. and R&D center, complete the upgrade and expansion from IVD automation to automation in the field of life sciences, become the first leading enterprise in the industry focusing on automation in the field of life sciences, and create new kinetic energy and new advantages to lead the development of the industry.